CDKN2A and neoplasm: In the case of faulty apoptosis mechanisms in the cell, for example, sustained mutations in p53 or ARF, overexpression of MDM2, and changes in the regulatory pathways of BCL-2 and NF-kB [54,55], high expression of MYC does not lead to the death of tumor cells.